| Line Item | 2024-12-28 | Y/Y |
|---|---|---|
| Revenue | $5.10B | +0.2% |
| R&D Expense | $5.1M | -13.6% |
| SG&A Expense | $2.00B | -5.6% |
| Operating Income | $348.3M | +101.5% |
| Interest Expense | $37.1M | +1.4% |
| Pre-tax Income | $328.9M | +109.4% |
| Income Tax | $80.8M | +139.9% |
| Net Income | $248.1M | +101.0% |
| EPS (Basic) | $1.18 |
| Line Item | 2024-12-28 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.0M | -77.8% |
| Inventory | $171.9M | -6.8% |
| Current Assets | $656.4M | -4.6% |
| Total Assets | $3.40B | -0.8% |
| Current Liabilities | $548.6M | -16.8% |
| Long-term Debt | $1.02B | -2.5% |
| Stockholders' Equity | $1.41B | +4.3% |
| Line Item | 2024-12-28 | Y/Y |
|---|---|---|
| Operating Cash Flow | $412.7M | +18.1% |
| Capital Expenditures | $132.1M | +2.3% |
| Investing Cash Flow | -$172.7M | +57.2% |
| Financing Cash Flow | -$257.5M | -192.1% |
| Free Cash Flow | $280.6M | +27.4% |
| +103.4% |
| EPS (Diluted) | $1.17 | +101.7% |